Heidelberg Pharma AG

Share Issue/Capital Change • Dec 3, 2009

News Details

Ad-hoc | 3 December 2009 18:24

WILEX AG closes capital increase

WILEX AG / Capital Increase

03.12.2009

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

• Not for distribution, publication or transmission in the USA, Canada,
  Japan and Australia -

WILEX AG closes capital increase

Munich, Germany, 3 December 2009 - WILEX AG (ISIN DE0006614720 /
Frankfurt/Main Stock Exchange / Prime Standard) announced today that it has
sold 2,177,030 new shares to qualified German and International investors
as a result of both the rights issue using authorised capital that was
completed as planned yesterday and the subsequent private placement of
unsubscribed shares. The Executive Management Board, with the approval of
the Supervisory Board, fixed the sale price for the private placement at
EUR 4.10, which is the same as the price under the subscription offer.

WILEX AG will receive gross proceeds of approximately EUR 8.93 million from
the capital increase. Following the entry of the capital increase in the
Commercial Register - which is scheduled for not later than 7 December 2009
- the total number of WILEX shares issued will increase to 15,957,965.

Bankhaus Sal. Oppenheim jr. & Cie. KGaA and Caris & Company, Inc. were the
joint lead managers und joint book-runners of the transaction.

Important notes
This ad-hoc release does not constitute either an offer to sell or an
invitation to buy securities. In particular, this document does not
constitute an offer to sell securities or a solicitation of an offer to buy
securities in the United States of America. The shares of WILEX AG (the
'Shares') may not be offered or sold in the United States of America or to
or for the account or benefit of 'U.S. persons' (as defined in Regulation S
under the U.S. Securities Act of 1933, as amended (the 'Securities Act')),
unless they have been registered or are exempt from registration under the
Securities Act. The Shares have not been and will not be registered under
the Securities Act. There will be no public offer of Shares in the United
States of America.

Contact
WILEX AG
Investor & Public Relations
Katja Arnold (CIRO))
Grillparzerstr. 10
81675 Munich; Germany
Tel.: +49 (0)89-41 31 38-126
Fax: +49 (0)89-41 31 38-99
E-mail: investors@wilex.com

This communication contains certain forward-looking statements, relating to
the Company's business, which can be identified by the use of
forward-looking terminology such as 'estimates', 'believes', 'expects',
'may', 'will' 'should' 'future', 'potential' or similar expressions or by
general discussion of strategy, plans or intentions of the Company. Such
forward-looking statements involve known and unknown risks, uncertainties
and other factors, which may cause our actual results of operations,
financial condition, performance, or achievements, or industry results, to
be materially different from any future results, performance or
achievements expressed or implied by such forward-looking statements. Given
these uncertainties, prospective investors and partners are cautioned not
to place undue reliance on such forward-looking statements. We disclaim any
obligation to update any such forward-looking statements to reflect future
events or developments. Given these uncertainties, prospective investors
and partners are cautioned not to place undue reliance on such
forward-looking statements. We disclaim any obligation to update any such
forward-looking statements to reflect future events or developments.

03.12.2009 Financial News distributed by DGAP. Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: WILEX AG
Grillparzerstr. 10
81675 München
Deutschland
Phone: +49 (0)89 41 31 38 - 0
Fax: +49 (0)89 41 31 38 - 99
E-mail: info@wilex.com
Internet: www.wilex.com
ISIN: DE0006614720
WKN: 661472
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, München, Stuttgart

End of News DGAP News-Service

---